As part of the celebration of innovation for the 30th anniversary of Ophthalmology Management, Himani Goyal, MD, cornea and anterior-segment specialist at NYU Langone Health and chief of service at Bellevue Hospital, discusses innovations in dry eye treatment that have transformed clinical practice. The below transcript has been edited for clarity.

Hi, my name is Himani Goyal. I'm a cornea and anterior-segment specialist up in New York. I'm affiliated with NYU Langone Health, and I'm also the chief of our service at Bellevue Hospital, which is our nation's first public hospital. We spend a whole lot of time teaching residents and also a big part of the faculty practice in Brooklyn. So we're here to talk about innovations that have affected our practice. I'd like to highlight dry eyes and how we've really embraced the treatment of it and the new tools that we have that have really changed our practice. One of the biggest things that we have done at NYU is that we actually hired a dry eye specialist, Dr. Mina Massaro, who's amazing. It's lovely to have someone who can actually focus on that, because a lot of these patients need TLC.

And she's also taught us a lot in just sort of the stepwise progression into what our tools are. The medications, I think as Demodex treatment or blepharitis treatment gets better with lotilaner (Xdemvy; Tarsus) and even prescription eye drops, including perfluorohexyloctane ophthalmic solution (Miebo; Bausch + Lomb) for dry eyes, now that they've been around for a few years and are getting to be more accessible, have really changed how we can treat our patients and their comfort. And it's really made our practice more fulfilling. And I think that because we have these tools available to us that are really working, and our patients are comfortably able to use them, it makes them happier. I do think that our outcomes are better, our visual acuities are better, whether it's in preparation for surgery, postsurgery, or not even related to that and lifestyle wise, because we realize that dry eyes affects very young patients as well as our older patients.

So it's a huge part of our lives now. And so we're really excited to help our patients.